This is historical material “frozen in time”. The website is no longer updated and links to external websites and some internal pages may not work.
We the people ask the federal government to Take or explain a position on an issue or policy:

Rescind the DEA's decision to classify CBD as a schedule I drug

Created by D.C. on December 17, 2016

CBD, the non-psychoactive drug in marijuana has hundreds of uses from Multiple Sclerosis, Huntington's disease, PTSD, to Rheumatoid Arthritis. The DEA has made the abominable choice to classify it as a drug with no medical uses. This terrible decision will negativley affect millions of disease sufferers. Please google 'CBD's use in diseases' for more information.

Government & Regulatory Reform
Health Care
Veterans & Military
Return to top